Search - tctmd.com

Displaying 181 - 200 of 271

Sort: Relevancy | Date

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Industry News

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

July 08, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Industry News

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

May 15, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

Todd Neale

April 29, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

News Daily News

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

L.A. McKeown

April 03, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

September 14, 2014

News Daily News

Pre-AMI Ischemia May Reduce Early Mortality

July 24, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Industry News

Biscayne Pharmaceuticals' GHRH Technology Featured In Presentations At International Society For Heart Research Meeting

May 14, 2014

News Industry News

The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions

May 01, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

Advertisement

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

MVARC Document Offers Template for Mitral Valve Therapeutics Research

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

CardioFocus' HeartLight® U.S. Pivotal Results Presented at Late-Breaking Clinical Trial Session at Heart Rhythm 2015

FDA Panel Backs Cangrelor for Use in PCI

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Experts Look to Big Data to Identify New Therapeutic Targets for CVD

Pre-AMI Ischemia May Reduce Early Mortality

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

Biscayne Pharmaceuticals' GHRH Technology Featured In Presentations At International Society For Heart Research Meeting

The Medicines Company and Alnylam Announce Presentation of New Pre-Clinical Data on PCSK9 at Arteriosclerosis, Thrombosis and Vascular Biology 2014 Scientific Sessions

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content